Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial

BACKGROUND: Azithromycin is a broad-spectrum antibiotic that has moderate antimalarial activity and has been shown to reduce all-cause mortality when biannually administered to children under five in high mortality settings in sub-Saharan Africa. One potential mechanism for this observed reduction i...

Descripción completa

Detalles Bibliográficos
Autores principales: Brogdon, Jessica, Dah, Clarisse, Sié, Ali, Bountogo, Mamadou, Coulibaly, Boubacar, Kouanda, Idrissa, Ouattara, Mamadou, Compaoré, Guillaume, Nebie, Eric, Seynou, Mariam, Lebas, Elodie, Nyatigo, Fanice, Hu, Huiyu, Arnold, Benjamin F., Lietman, Thomas M., Oldenburg, Catherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957146/
https://www.ncbi.nlm.nih.gov/pubmed/35337289
http://dx.doi.org/10.1186/s12879-022-07296-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957146/
https://www.ncbi.nlm.nih.gov/pubmed/35337289
http://dx.doi.org/10.1186/s12879-022-07296-4

Ejemplares similares